We are live on ! Find out more
ICUI icon

ICU Medical

277 hedge funds and large institutions have $4.17B invested in ICU Medical in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 91 increasing their positions, 96 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

669% more call options, than puts

Call options by funds: $23.7M | Put options by funds: $3.09M

1% more capital invested

Capital invested by funds: $4.12B → $4.17B (+$52.5M)

0.68% more ownership

Funds ownership: 95%95.68% (+0.68%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 96

4% less funds holding

Funds holding: 288277 (-11)

32% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 34

Holders
277
Holders Change
-11
Holders Change %
-3.82%
% of All Funds
4.82%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
91
Reduced
96
Closed
34
Calls
$23.7M
Puts
$3.09M
Net Calls
+$20.6M
Net Calls Change
+$818K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$32.9M +$1.56M +7,602 +5%
PVI
27
Pura Vida Investments
New York
$30.8M +$258K +1,254 +0.8%
Bank of America
28
Bank of America
North Carolina
$30.7M +$1.05M +5,120 +4%
BTW
29
Boston Trust Walden
Massachusetts
$28.6M -$804K -3,908 -3%
Wells Fargo
30
Wells Fargo
California
$27.8M +$2.54M +12,332 +10%
EAM
31
Eagle Asset Management
Florida
$27M +$10.8M +52,453 +67%
GKIM
32
GW&K Investment Management
Massachusetts
$25.6M -$47.1K -229 -0.2%
Federated Hermes
33
Federated Hermes
Pennsylvania
$25.3M +$968K +4,707 +4%
Ameriprise
34
Ameriprise
Minnesota
$20.2M +$523K +2,542 +3%
RJA
35
Raymond James & Associates
Florida
$20.1M +$4.51M +21,919 +29%
KCM
36
Kennedy Capital Management
Missouri
$18.7M +$17.7M +86,018 +1,786%
Deutsche Bank
37
Deutsche Bank
Germany
$17.6M +$2.77M +13,466 +19%
GT
38
Glenmede Trust
Pennsylvania
$16.8M -$29.8K -145 -0.2%
First Trust Advisors
39
First Trust Advisors
Illinois
$16.8M +$5.03M +24,453 +43%
AQR Capital Management
40
AQR Capital Management
Connecticut
$15.3M -$3.51M -17,047 -18%
TD Asset Management
41
TD Asset Management
Ontario, Canada
$14.3M -$2.25M -10,920 -13%
Principal Financial Group
42
Principal Financial Group
Iowa
$14.1M +$168K +817 +1%
WCM Investment Management
43
WCM Investment Management
California
$13.2M +$13.2M +64,259 New
PPA
44
Parametric Portfolio Associates
Washington
$13.2M +$192K +932 +1%
Renaissance Technologies
45
Renaissance Technologies
New York
$11.4M +$4.79M +23,300 +73%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$11.3M -$152K -739 -1%
GF
47
Gabelli Funds
New York
$10.1M -$206K -1,000 -2%
Millennium Management
48
Millennium Management
New York
$10.1M +$6.63M +32,235 +194%
SI
49
Scout Investments
Missouri
$10M -$838K -4,075 -8%
PCA
50
Personal Capital Advisors
California
$9.9M +$847K +4,116 +9%

ICUI Hedge Fund Activity: Q2 2021 in Review

277 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q2 2021, worth a combined $4.17B — up 1.3% from $4.12B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of ICUI and 23 opened new positions — a net loss of 11 holders — while 96 trimmed existing stakes and 91 added.

The largest buyer was Nuance Investments, adding an estimated $67.1M. The largest seller was T. Rowe Price Associates, cutting an estimated $41.4M.

  • 277 institutional investors held ICU Medical (ICUI) as of Q2 2021, down from 288 in Q1 2021.
  • Funds reported $4.17B of ICU Medical stock for Q2 2021, up 1.3% quarter-over-quarter.
  • 23 funds opened new ICU Medical positions in Q2 2021 and 34 closed out, a net change of -11 holders.
  • The largest ICU Medical buyer in Q2 2021 was Nuance Investments, an estimated $67.1M added.
  • The largest ICU Medical seller in Q2 2021 was T. Rowe Price Associates, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2021.